These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29974459)

  • 1. Implementation of a new strategy to improve the peri-operative management of neuromuscular blockade and its effects on postoperative pulmonary complications.
    Rudolph MI; Chitilian HV; Ng PY; Timm FP; Agarwala AV; Doney AB; Ramachandran SK; Houle TT; Eikermann M
    Anaesthesia; 2018 Sep; 73(9):1067-1078. PubMed ID: 29974459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised controlled trial of sugammadex or neostigmine for reversal of neuromuscular block on the incidence of pulmonary complications in older adults undergoing prolonged surgery.
    Togioka BM; Yanez D; Aziz MF; Higgins JR; Tekkali P; Treggiari MM
    Br J Anaesth; 2020 May; 124(5):553-561. PubMed ID: 32139135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic doses of neostigmine, depolarising neuromuscular blockade and muscle weakness in awake volunteers: a double-blind, placebo-controlled, randomised volunteer study.
    Kent NB; Liang SS; Phillips S; Smith NA; Khandkar C; Eikermann M; Stewart PA
    Anaesthesia; 2018 Sep; 73(9):1079-1089. PubMed ID: 30132821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery of muscle function after deep neuromuscular block by means of diaphragm ultrasonography and adductor of pollicis acceleromyography with comparison of neostigmine vs. sugammadex as reversal drugs: study protocol for a randomized controlled trial.
    Cappellini I; Picciafuochi F; Ostento D; Danti G; De Gaudio AR; Adembri C
    Trials; 2018 Feb; 19(1):135. PubMed ID: 29467022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent Association between Intermediate-acting Neuromuscular-blocking Agents and Postoperative Respiratory Complications.
    McLean DJ; Diaz-Gil D; Farhan HN; Ladha KS; Kurth T; Eikermann M
    Anesthesiology; 2015 Jun; 122(6):1201-13. PubMed ID: 25919486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of residual neuromuscular block with neostigmine or sugammadex and postoperative pulmonary complications: a prospective, randomised, double-blind trial in high-risk older patients.
    Ledowski T; Szabó-Maák Z; Loh PS; Turlach BA; Yang HS; de Boer HD; Asztalos L; Shariffuddin II; Chan L; Fülesdi B
    Br J Anaesth; 2021 Aug; 127(2):316-323. PubMed ID: 34127252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between choice of reversal agent for neuromuscular block and postoperative pulmonary complications in patients at increased risk undergoing non-emergency surgery: STIL-STRONGER, a multicentre matched cohort study.
    Colquhoun DA; Vaughn MT; Bash LD; Janda A; Shah N; Ghaferi A; Sjoding M; Mentz G; Kheterpal S;
    Br J Anaesth; 2023 Jan; 130(1):e148-e159. PubMed ID: 35691703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nondepolarizing Neuromuscular Blocking Agents, Reversal, and Risk of Postoperative Pneumonia.
    Bulka CM; Terekhov MA; Martin BJ; Dmochowski RR; Hayes RM; Ehrenfeld JM
    Anesthesiology; 2016 Oct; 125(4):647-55. PubMed ID: 27496656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
    Carron M; Zarantonello F; Tellaroli P; Ori C
    J Clin Anesth; 2016 Dec; 35():1-12. PubMed ID: 27871504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of rocuronium neuromuscular block using a protocol for qualitative monitoring and reversal with neostigmine.
    Thilen SR; Ng IC; Cain KC; Treggiari MM; Bhananker SM
    Br J Anaesth; 2018 Aug; 121(2):367-377. PubMed ID: 30032875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a peri-operative quality improvement programme on postoperative pulmonary complications.
    Moore JA; Conway DH; Thomas N; Cummings D; Atkinson D
    Anaesthesia; 2017 Mar; 72(3):317-327. PubMed ID: 28054356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of complications in the post-anesthesia care unit and associated healthcare utilization in patients undergoing non-cardiac surgery requiring neuromuscular blockade 2005-2013: A single center study.
    Belcher AW; Leung S; Cohen B; Yang D; Mascha EJ; Turan A; Saager L; Ruetzler K
    J Clin Anesth; 2017 Dec; 43():33-38. PubMed ID: 28972924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective investigation of postoperative outcome after reversal of residual neuromuscular blockade: sugammadex, neostigmine or no reversal.
    Ledowski T; Falke L; Johnston F; Gillies E; Greenaway M; De Mel A; Tiong WS; Phillips M
    Eur J Anaesthesiol; 2014 Aug; 31(8):423-9. PubMed ID: 24296853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of neostigmine reversal of nondepolarizing neuromuscular blocking agents on postoperative respiratory outcomes: a prospective study.
    Sasaki N; Meyer MJ; Malviya SA; Stanislaus AB; MacDonald T; Doran ME; Igumenshcheva A; Hoang AH; Eikermann M
    Anesthesiology; 2014 Nov; 121(5):959-68. PubMed ID: 25225821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children.
    Ammar AS; Mahmoud KM; Kasemy ZA
    Acta Anaesthesiol Scand; 2017 Apr; 61(4):374-380. PubMed ID: 28185260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How robust are the STRONGER and STIL-STRONGER studies?
    Blobner M; Hunter JM; Ulm K
    Br J Anaesth; 2023 Jan; 130(1):e41-e44. PubMed ID: 36182557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observational study on patterns of neuromuscular blockade reversal.
    Dubovoy T; Housey M; Devine S; Kheterpal S
    BMC Anesthesiol; 2016 Oct; 16(1):103. PubMed ID: 27770778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neostigmine injected 5 minutes after low-dose rocuronium accelerates the recovery of neuromuscular function.
    Lederer W; Reiner T; Khuenl-Brady KS
    J Clin Anesth; 2010 Sep; 22(6):420-4. PubMed ID: 20868962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of sugammadex vs. neostigmine on postoperative respiratory complications and advanced healthcare utilisation: a multicentre retrospective cohort study.
    Suleiman A; Munoz-Acuna R; Azimaraghi O; Houle TT; Chen G; Rupp S; Witt AS; Azizi BA; Ahrens E; Shay D; Wongtangman K; Wachtendorf LJ; Tartler TM; Eikermann M; Schaefer MS
    Anaesthesia; 2023 Mar; 78(3):294-302. PubMed ID: 36562202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.